Company has a lot of potential with their pipeline
MIEP's pipeline of drugs for blood cancers is greatly undervalued here. Once they start releasing results of phase 2 trials this company will fly up as Johnson and Johnson, Celgene,Novartis and others are looking to acquire companies in this area.
watch for big pharma to pounce on ICPT. ONLY company in space that will dominate it.
If the CFO is touting that FTC is coming with no real action to institutional investors as he is on road show, HLF must have already been given verbal of that and is waiting for written form to make formal announcement, otherwise why would he be saying it...... along with spending for a massive advertising campaign starting this week......hmmm cards are about to be played......
lol, your the scam!!!
This company already did a capital raise in December and has enough till end of 2016
CYTR ready to explode to the upside. Way too many big catalyst happening this year!
watch for quick run to 5.00
Merck, Lilly, Novartis, Celgene, Bristol Meyers, all need to be in the next multi billion dollar drug coming for unmet need.
with all the positive news coming out i can see that. Next up is big pharma sniffing around here.
all other restaurants are flying and making money with low gas prices and commodities, NDLS can't get out of its own way! Time to fire them!
technology and efficacy is too good, that a number of big pharma will rush to buy them out.
mid teens coming
with strong cash flow alone from Nitrogen assets and premium pricing they get because of geographical advantage, we are looking at mid 20's on buyout